847337-63-7
847337-63-7
Chemical Structure
KRAS G12C inhibitor 29
- CAS No.: 847337-63-7
- Formula:C23H21ClFN5O2
- Molecular Weight:453.90
IUPAC Name: 3-(2-chloro-6-fluorobenzyl)-1-methyl-9-(m-tolyl)-6,7,8,9-tetrahydropyrimido[2,1-f]purine-2,4(1H,3H)-dione
InChIKey: GWEBJSRHSQNRTI-UHFFFAOYSA-N
SMILES: O=C(N1CC2=C(F)C=CC=C2Cl)N(C)C3=C(N4C(N(C5=CC=CC(C)=C5)CCC4)=N3)C1=O
Biological Activity: KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
KRAS G12C inhibitor 29 | KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
